A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/19 (2006.01) A61K 9/06 (2006.01) A61K 9/08 (2006.01) A61P 27/04 (2006.01)
Patent
CA 2541302
It is intended to provide an ophthalmic composition characterized by containing 3-hydroxybutyric acid and/or its salt as the active ingredient(s) and being used for preventing eyes from dryness and, in its turn, an ophthalmic composition characterized by being used for treating lacrimal disorders. By using the above ophthalmic composition, eyes can be prevented from dryness and, in its turn, lacrimal disorders can be treated. Thus, use of the composition makes it possible to ameliorate unpleasant symptoms caused by lacrimal disorders such as eye dryness, foreign-body sensation, eye unpleasantness and eye fatigue. Moreover, this ophthalmic composition can prevent the onset of diseases caused by lacrimal disorders such as dry eye and suspected cases of dry eye. More specifically speaking, it can prevent the onset of diseases caused by lacrimal disorders without injuring cornea or conjunctiva.
L'invention concerne une composition ophtalmique caractérisée en ce qu'elle contient de l'acide 3-hydroxybutyrique et/ou son sel en tant que principe(s) actif(s), qui est destinée à empêcher la sécheresse des yeux et s'utilise par la même pour le traitement des troubles lacrymaux. Cette composition permet d d'atténuer des symptômes désagréables provoqués par des troubles lacrymaux tels que sécheresse oculaire, sensation de présence d'un corps étranger, désagrément oculaire, fatigue de l'oeil. De plus, cette composition ophtalmique peut empêcher l'apparition de maladies provoquées par des troubles lacrymaux telles que sécheresse de l'oeil avérée ou présumée. Plus précisément, cette composition peut empêcher l'apparition de maladies dues à des troubles lacrymaux sans lésion de la cornée ou de la conjonctive.
Nakamura Shigeru
Nakashima Hideo
Okada Shoji
Saitoh Yasukazu
Shibuya Michiko
Ophtecs Corporation
Smart & Biggar
LandOfFree
Ophthalmic composition for treating tear dysfunction does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ophthalmic composition for treating tear dysfunction, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ophthalmic composition for treating tear dysfunction will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1985220